INNV InnovAge Holding Corp.
Healthcare$7.35+2.08%ClosedMarket Cap: $997.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.27
P/S
1.03
EV/EBITDA
16.73
DCF Value
$-5.58
FCF Yield
4.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
20.7%
Operating Margin
3.9%
Net Margin
-2.3%
ROE
-9.2%
ROA
-4.1%
ROIC
10.2%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 null | $251.9M | 22.3% | $22.8M | $-29.5M | $— | — |
| Q2 null | $239.7M | 20.0% | $16.1M | $10.6M | $— | — |
| Q1 null | $236.1M | 21.8% | $8.3M | $8.0M | $— | — |
| Q4 null | $218.1M | 18.7% | $-10.2M | $-11.4M | $— | — |
| FY null | $853.7M | 68.5% | $-29.8M | $-30.3M | $— | — |
| Q3 null | $218.1M | 18.7% | $-10.2M | $-11.4M | $— | — |
| Q2 null | $209.0M | 17.7% | $-12.6M | $-13.2M | $— | — |
| Q1 null | $205.1M | 16.8% | $-4.9M | $-4.9M | $— | — |
| Q4 null | $199.4M | 18.3% | $-4.9M | $-1.7M | $— | — |
| FY null | $763.9M | 17.3% | $-23.2M | $-21.3M | $— | — |
| Q3 null | $193.1M | 17.6% | $-5.8M | $-5.9M | $— | — |
| Q2 2024 | $188.9M | 17.8% | $-1.8M | $-3.4M | $-0.03 | — |